Sensitive method for detection of cocaine and associated analytes by liquid chromatography-tandem mass spectrometry in urine

Journal of Analytical Toxicology

Volumn 33, Issue 8, 2009, Pages 447-455

  Langman, Loralie J ^a   Bjergum, Matthew W ^a   Williamson, Christopher L ^b   Crow, Frank W ^a  

^a MAYO CLINIC   (United States)

^b ESCgov Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ANHYDROECGONINE ETHYL ESTER; ANHYDROECGONINE METHYL ESTER; BENZOYLECGONINE; COCAINE; HOMOCOCAINE; M HYDROXYBENZOYLECGONINE; METHANOL; NORCOCAINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FLOW RATE; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 70350501864     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.8.447     Document Type: Article

References (67)

1. D.S. Isenschmid. Cocaine. In Principles of Forensic Toxicology, 2nd ed., B. Levine, Ed. AACC Press,Washington, D.C., 2003, pp 207-228.
2. D.S. Isenschmid. Cocaine - effects on human performance and behavior. Forensic Sci. Rev. 14: 61 (2002).
3. Cocaine. http://www.usdoj.gov/dea/concern/cocaine.html. Accessed February 5, 2008.
4. NIDA InfoFacts: Crack and Cocaine. http://www.nida.nih.gov/Info facts/cocaine.html. Accessed February 5, 2008.
5. Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings, NSDUH Series H-34, DHHS Publication No. SMA 08-4343. Office of Applied Studies, SAMHSA, Rockville, MD, 2008.
6. R.A. Dean, C.D. Christian, R.H. Sample, and W.F. Bosron. Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J. 5: 2735-2739 (1991).
7. E.A. Kolbrich, A.J. Barnes, D.A. Gorelick, S.J. Boyd, E.J. Cone, and M.A. Huestis. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J. Anal. Toxicol. 30: 501-510 (2006).
8. C. Moore, A. Negrusz, and D. Lewis. Determination of drugs of abuse in meconium. J. Chromatogr. B Biomed. Sci. Appl. 713: 137-146 (1998).
9. B.M. Lester, M.A. ElSohly, L.L. Wright, V.L. Smeriglio, J. Verter, C.R. Bauer, S. Shankaran, H.S. Bada, H.H. Walls, M.A. Huestis, L.P. Finnegan, and P.L. Maza. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics. 107: 309-317 (2001).
10. K.L. Klette, G.K. Poch, R. Czarny, and C.O. Lau. Simultaneous GC-MS analysis of meta- and para-hydroxybenzoylecgonine and norbenzoylecgonine: a secondary method to corroborate cocaine ingestion using nonhydrolytic metabolites. J. Anal. Toxicol. 24: 482-488 (2000).
11. M.W. Kloss, G.M. Rosen, and E.J. Rauckman. N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol. Pharmacol. 23: 482-485 (1983).
12. M.W. Kloss, G.M. Rosen, and E.J. Rauckman. Cocaine-mediated hepatotoxicity. A critical review. Biochem. Pharmacol. 33: 169-173 (1984).
13. F. Boess, F.M. Ndikum-Moffor, U.A. Boelsterli, and S.M. Roberts. Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species. Biochem. Pharmacol. 60: 615-623 (2000).
14. T. Inaba, D.J. Stewart, and W. Kalow. Metabolism of cocaine in man. Clin. Pharmacol. Ther. 23: 547-552 (1978).
15. M. Farré, R. de la Torre, M. Llorente, X. Lamas, B. Ugena, J. Segura, and J. Camí. Alcohol and cocaine interactions in humans. J. Pharmacol. Exp. Ther. 266: 1364-1373 (1993).
16. W.L. Hearn, D.D. Flynn, G.W. Hime, S. Rose, J.C. Cofino, E. Mantero- Atienza, C.V.Wetli, and D.C. Mash. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J. Neurochem. 56: 698-701 (1991).
17. P. Jatlow, J.D. Elsworth, C.W. Bradberry, G. Winger, J.R. Taylor, R. Russell, and R.H. Roth. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 48: 1787-1794 (1991).
18. M.R. Brzezinski, T.L. Abraham, C.L. Stone, R.A. Dean, and W.F. Bosron. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem. Pharmacol. 48: 1747-1755 (1994).
19. E.F. McCance-Katz, L.H. Price, C.J. McDougle, T.R. Kosten, J.E. Black, and P.I. Jatlow. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 111: 39-46 (1993).
20. C.L. Hart, P. Jatlow, K.A. Sevarino, and E.F. McCance-Katz. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology (Berl). 149: 153-162 (2000).
21. M. Perez-Reyes, A.R. Jeffcoat, M. Myers, K. Sihler, and C.E. Cook. Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. Psychopharmacology (Berl). 116: 428-432 (1994).
22. P. Andrews. Cocaethylene toxicity. J.Addict Dis. 16: 75-84 (1997).
23. V.W. Vanek, H.I. Dickey-White, S.A. Signs, M.D. Schechter, T. Buss, and A.T. Kulics. Concurrent use of cocaine and alcohol by patients treated in the emergency department. Ann. Emerg. Med. 28: 508-514 (1996).
24. E.J. Cone, M. Hillsgrove, and W.D. Darwin. Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin. Chem. 40: 1299-1305 (1994).
25. A.J. Jenkins and B.A. Goldberger. Identification of unique cocaine metabolites and smoking by-products in postmortem blood and urine specimens. J. Forensic Sci. 42: 824-827 (1997).
26. R.M. Smith. Ethyl esters of arylhydroxy- and arylhydroxymethoxycocaines in the urines of simultaneous cocaine and ethanol users. J. Anal. Toxicol. 8: 38-42 (1984).
27. B.D. Paul, S. Lalani, T. Bosy, A.J. Jacobs, and M.A. Huestis. Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. Biomed. Chromatogr. 19: 677-688 (2005).
28. R.A. Jufer, S.L.Walsh, and E.J. Cone. Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use. J. Anal. Toxicol. 22: 435-444 (1998).
29. A. Klingmann, G. Skopp, and R. Aderjan. Analysis of cocaine, benzoylecgonine, ecogonine methyl ester, and ecgonine by high-pressure liquid chromatography-API mass spectrometry and application to a short-term degradation study of cocaine in plasma. J. Anal. Toxicol. 25: 425-430 (2001).
30. P.M. Jeanville, E.S. Estape, S.R. Needham, and M.J. Cole. Rapid confirmation/quantitation of cocaine and benzoylecgonine in urine utilizing high performance liquid chromatography and tandem mass spectrometry. J. Am. Soc.Mass Spectrom. 11: 257-263 (2000).
31. P.P. Robandt, L. J. Reda, and K.L. Klette. Complete automation of solid-phase extraction with subsequent liquid chromatography-tandem mass spectrometry for the quantification of benzoylecgonine, m- hydroxybenzoylecgonine, p-hydroxybenzoylecgonine, and norbenzoylecgonine in urine - application to a high-throughput urine analysis laboratory. J. Anal. Toxicol. 32: 577-585 (2008).
32. S.R. Needham, P.M. Jeanville, P.R. Brown, and E.S. Estape. Performance of a pentafluorophenylpropyl stationary phase for the electrospray ionization high-performance liquid chromatography- mass spectrometry-mass spectrometry assay of cocaine and its metabolite ecgonine methyl ester in human urine. J. Chromatogr. B Biomed. Sci. Appl. 748: 77-87 (2000).
33. Q.R. Sun, P. Xiang, H. Yan, and M. Shen. Simultaneous analyses of cocaine and its metabolite benzoylecgonine in urine by LC-MS/MS. Fa Yi Xue Za Zhi. 24: 268-272 (2008) (in Chinese).
34. J. Feng, L. Wang, I. Dai, T. Harmon, and J.T. Bernert. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS. J. Anal. Toxicol. 31: 359-368 (2007).
35. S.S. Johansen and H.M. Bhatia. Quantitative analysis of cocaine and its metabolites in whole blood and urine by high-performance liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 852: 338-344 (2007).
36. EP15-A2.User Verification of Performance for Precision and Trueness; Approved Guideline, 2nd ed. Clinical and Laboratory Standards Institute, Pennsylvania, PA, 2006.
37. D.T. Burns, K. Danzer, and A. Townshend. Use of the terms "recovery" and "apparent recovery" in analytical procedures (IUPAC Recommendations 2002). Pure Appl. Chem. 74: 2201-2205 (2002).
38. T.M. Annesley. Ion suppression in mass spectrometry. Clin. Chem. 49: 1041-1044 (2003).
39. Y. Xia, P.Wang, M.G. Bartlett, H.M. Solomon, and K.L. Busch. An LC-MS-MS method for the comprehensive analysis of cocaine and cocaine metabolites in meconium. Anal. Chem. 72: 764-771 (2000).
40. J.I. Javaid, H. Dekirmenjian, E.G. Brunngraber, and J.M. Davis. Quantitative determination of cocaine and its metabolites benzoylecgonine and ecgonine by gas-liquid chromatography. J. Chromatogr. 110: 140-149 (1975).
41. J.E. Wallace, H.E. Hamilton, D.E. King, D.J. Bason, H.A. Schwertner, and S.C. Harris. Gas-liquid chromatographic determination of cocaine and benzoylecgonine in urine. Anal. Chem. 48: 34-38 (1976).
42. N.C. Jain, D.M. Chinn, R.D. Budd, T.S. Sneath, and W.J. Leung. Simultaneous determination of cocaine and benzoyl ecgonine in urine by gas chromatography with on-column alkylation. J. Forensic Sci. 22: 7-16 (1977).
43. M.J. Kogan, K.G. Verebey, A.C. DePace, R.B. Resnick, and S.J. Mule. Quantitative determination of benzoylecgonine and cocaine in human biofluids by gas-liquid chromatography. Anal. Chem. 49: 1965-1969 (1977).
44. D.L. von Minden and N.A. D'Amato. Simultaneous determination of cocaine and benzoylecgonine in urine by gas-liquid chromatography. Anal. Chem. 49: 1974-1977 (1977).
45. J. Ortuño, R. de la Torre, J. Segura, and J. Camí. Simultaneous detection in urine of cocaine and its main metabolites. J. Pharm. Biomed. Anal. 8: 911-914 (1990).
46. D.S. Isenschmid, B.S. Levine, and Y.H. Caplan. A method for the simultaneous determination of cocaine, benzoylecgonine, and ecgonine methyl ester in blood and urine using GC/EIMS with derivatization to produce high mass molecular ions. J. Anal. Toxicol. 12: 242-245 (1988).
47. G.W. Hime, W.L. Hearn, S. Rose, and J. Cofino. Analysis of cocaine and cocaethylene in blood and tissues by GC-NPD and GC-ion trap mass spectrometry. J. Anal. Toxicol. 15: 241-245 (1991).
48. M.R. Corburt and E.M. Koves. Gas chromatography/mass spectrometry for the determination of cocaine and benzoylecgonine over a wide concentration range (< 0.005-5 mg/dL) in postmortem blood. J. Forensic Sci. 39: 136-149 (1994).
49. R. de la Torre, J. Ortuño, M.L. González, M. Farré, J. Camí, and J. Segura. Determination of cocaine and its metabolites in human urine by gas chromatography/mass spectrometry after simultaneous use of cocaine and ethanol. J. Pharm. Biomed. Anal. 13: 305-312 (1995).
50. D. Smirnow and B.K. Logan. Analysis of ecgonine and other cocaine biotransformation products in postmortem whole blood by protein precipitation-extractive alkylation and GC-MS. J. Anal. Toxicol. 20: 463-467 (1996).
51. A.C. Spanbauer, D.E. Moody, R.L. Foltz, and S.L. Walsh. A gas chromatographic-positive ion chemical ionization-mass spectrometric method for determination of cocaine, benzoylecgonine, ecgonine methyl ester, and norcocaine in plasma: detection of norcocaine in plasma after oral administration of cocaine. J. Anal. Toxicol. 24: 453-455 (2000).
52. A.N. Masoud and D.M. Krupski. High-performance liquid chromatographic analysis of cocaine in human plasma. J. Anal. Toxicol. 4: 305-310 (1980).
53. R.L. Miller and C.L. DeVane. Determination of cocaine, benzoylecgonine and ecgonine methyl ester in plasma by reversed-hase high-performance liquid chromatography. J. Chromatogr. 570: 412-418 (1991).
54. J. Sukbuntherng, A. Walters, H.H. Chow, and M. Mayersohn. Quantitative determination of cocaine, cocaethylene (ethylcocaine), and metabolites in plasma and urine by high-performance liquid chromatography. J. Pharm. Sci. 84: 799-804 (1995).
55. K.M. Clauwaert, J.F. Van Bocxlaer, W.E. Lambert, and A.P. De Leenheer. Liquid chromatographic determination of cocaine, benzoylecgonine, and cocaethylene in whole blood and serum samples with diode-array detection. J. Chromatogr. Sci. 35: 321-328 (1997).
56. New York State Clinical Laboratory Standards of Practice, Quality Control Sustaining Standard of Practice 3 (QC SS3).
57. College of American Pathologists 2008 Chemistry and Toxicology Accreditation Checklist.
58. T. Lukaszewski andW. Jeffery. Impurities and artifacts of illicit cocaine. J. Forensic Sci. 25: 499-508 (1980).
59. P. Jacob, III, E.R. Lewis, B.A. Elias-Baker, and R.T. Jones. A pyrolysis product, anhydroecgonine methyl ester (methylecgonidine), is in the urine of cocaine smokers. J. Anal. Toxicol. 14: 353-357 (1990).
60. S.W. Toennes, A.S. Fandino, and G. Kauert. Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crack. J. Chromatogr. B Biomed. Sci. Appl. 735: 127-132 (1999).
61. J. Ambre, M. Fischman, and T.I. Ruo. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J. Anal. Toxicol. 8: 23-25 (1984).
62. J. Ambre, T.I. Ruo, J. Nelson, and S. Belknap. Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans. J. Anal. Toxicol. 12: 301-306 (1988).
63. J. Ambre. The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data. J. Anal. Toxicol. 9: 241-245 (1985).
64. D.N. Bailey. Serial plasma concentrations of cocaethylene, cocaine, and ethanol in trauma victims. J. Anal. Toxicol. 17: 79-83 (1993).
65. P. Jacob, J.E. Mendelson, R.T. Jones, and N.L. Benowitz. Formation and elimination kinetics of cocaethylene in humans. Clin. Pharmacol. Ther. 53: 174 (1993).
66. P. Jatlow. Cocaethylene: pharmacologic activity and clinical significance. Ther. Drug. Monit. 15: 533-536 (1993).
67. E.J. Cone, A.H. Sampson-Cone,W.D. Darwin, M.A. Huestis, and J.M. Oyler. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J. Anal. Toxicol. 27: 386-401 (2003).